Total Payments
$1,435
2024 Payments
$107.80
Companies
7
Transactions
12
Medicare Patients
1,030
Medicare Billing
$242,631
Payment Breakdown by Category
Travel$963.69 (67.1%)
Food & Beverage$470.63 (32.8%)
Education$0.94 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $963.69 | 2 | 67.1% |
| Food and Beverage | $470.63 | 9 | 32.8% |
| Education | $0.94 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | $1,028 | 4 | $0 (2019) |
| Abbott Laboratories | $140.38 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $118.94 | 2 | $0 (2022) |
| Novo Nordisk Inc | $107.80 | 1 | $0 (2024) |
| Genentech USA, Inc. | $22.35 | 2 | $0 (2017) |
| Medtronic USA, Inc. | $16.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.80 | 1 | Novo Nordisk Inc ($107.80) |
| 2022 | $107.59 | 1 | AstraZeneca Pharmaceuticals LP ($107.59) |
| 2020 | $11.35 | 1 | AstraZeneca Pharmaceuticals LP ($11.35) |
| 2019 | $1,169 | 5 | Boehringer Ingelheim International GmbH ($1,028) |
| 2017 | $39.95 | 4 | Genentech USA, Inc. ($22.35) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $107.80 | General |
| 11/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $107.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2019 | Abbott Laboratories | S-Series SCS Leads (Device) | Food and Beverage | In-kind items and services | $140.38 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $881.60 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $82.09 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: DIABETES | ||||||
| 09/19/2017 | Medtronic USA, Inc. | — | Food and Beverage | In-kind items and services | $16.66 | General |
| 08/28/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: BioOncology/Immunology | ||||||
| 07/19/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: BioOncology/Immunology | ||||||
| 01/10/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.94 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 176 | 287 | $89,375 | $20,503 |
| 2022 | 5 | 204 | 396 | $154,818 | $40,374 |
| 2021 | 7 | 264 | 649 | $208,568 | $70,397 |
| 2020 | 10 | 386 | 4,947 | $399,889 | $111,358 |
Total Patients
1,030
Total Services
6,279
Medicare Billing
$242,631
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 155 | $44,840 | $10,192 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 97 | $37,798 | $8,472 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 35 | $6,737 | $1,839 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 228 | $65,958 | $15,029 | 22.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 14 | 55 | $48,007 | $14,989 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 83 | $32,343 | $8,286 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,853 | $1,243 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 19 | $3,657 | $826.75 | 22.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 93 | $81,175 | $26,859 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 255 | $73,769 | $25,685 | 34.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 66 | $25,718 | $9,504 | 37.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 42 | 72 | $10,080 | $4,184 | 41.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $5,295 | $1,543 | 29.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 132 | $8,874 | $1,513 | 17.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 19 | $3,657 | $1,110 | 30.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 32 | 156 | $136,165 | $36,197 | 26.6% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2020 | 16 | 4,077 | $111,302 | $31,443 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 192 | $55,544 | $15,619 | 28.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 70 | 112 | $43,643 | $12,469 | 28.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 19 | 29 | $20,390 | $5,510 | 27.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 54 | 75 | $10,500 | $4,416 | 42.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 27 | $5,400 | $2,207 | 40.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 174 | $11,698 | $2,064 | 17.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 23 | $4,427 | $1,240 | 28.0% |
| 85018 | Hemoglobin measurement | Office | 2020 | 12 | 82 | $820.00 | $193.54 | 23.6% |
About Dr. Gregory Braden, MD
Dr. Gregory Braden, MD is a Nephrology healthcare provider based in West Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609866755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Braden, MD has received a total of $1,435 in payments from pharmaceutical and medical device companies, with $107.80 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($963.69).
As a Medicare-enrolled provider, Braden has provided services to 1,030 Medicare beneficiaries, totaling 6,279 services with total Medicare billing of $242,631. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location West Springfield, MA
- Active Since 10/28/2005
- Last Updated 01/11/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1609866755
Products in Payments
- JARDIANCE (Drug) $1,028
- S-Series SCS Leads (Device) $140.38
- FARXIGA (Drug) $107.59
- Rituxan (Biological) $22.35
- LOKELMA (Drug) $11.35
- (815) Thiola (Drug) $0.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in West Springfield
Dr. Jeffrey Mulhern, Md, MD
Nephrology — Payments: $877.13
Nephrology $877.13
Dr. Daniel Landry, D.o, D.O
Nephrology — Payments: $491.41
Nephrology $491.41
Dr. Arley Diaz, Md, MD
Nephrology — Payments: $70.38
Nephrology $70.38
Dr. Anthony Poindexter, Md, MD
Nephrology — Payments: $45.09
Nephrology $45.09
Dr. Spencer Hodgins, M.d, M.D
Nephrology
Nephrology